keyword
https://read.qxmd.com/read/38642252/association-between-anti-pl7-antibodies-and-increased-fibrotic-component-in-patients-with-antisynthetase-syndrome-and-interstitial-lung-disease-a-cross-sectional-study
#1
JOURNAL ARTICLE
Daphne Rivero-Gallegos, Mayra Mejía, Héctor I Rocha-González, Juan C Huerta-Cruz, Ramcés Falfán-Valencia, Espiridion Ramos-Martínez, Heidegger N Mateos-Toledo, María F Castillo-López, Yeimi K Rodríguez-Torres, Valeria Lira-Boussart, Jorge Rojas-Serrano
OBJECTIVE: To evaluate whether anti-PL7 and anti-PL12 autoantibodies are associated with a greater extent of the fibrotic component of ILD in ASSD patients. METHODS: Patients with ILD-ASSD who were positive for one of the following autoantibodies: anti-Jo1, anti-PL7, anti-PL12, and anti-EJ were included. Clinical manifestations, CPK levels, pulmonary function tests, and HCRT assessments were prospectively collected according to the Goh index. The fibrotic, inflammatory, and overall extension of the Goh index and DLCO were assessed by multiple linear analyses and compared between ASSD antibody subgroups...
April 20, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38584892/an-acute-infection-due-to-hepatitis-e-in-the-context-of-a-patient-with-rituximab-and-methotrexate-therapy
#2
JOURNAL ARTICLE
Francisco Josué Cordero Pérez, Eva P Martín-Garrido, Marta Antona-Herranz, Carmen Bailador-Andrés, Pilar Conde-Gacho, Clara de Diego-Cobos, Santiago J Rodriguez-Gomez
BACKGROUND: This report presents the influence of immunosuppression by new rheumatological therapies on hepatitis E virus infection in a 54-year-old male patient with an anti-synthetase syndrome and treatment with methotrexate and rituximab. CASE DESCRIPTION: The patient arrived at the Emergency Department with epigastric pain, vomiting and dark urine. Initial examination revealed signs of inflammation and hepatic dysfunction. Subsequent laboratory tests and imaging confirmed acute hepatitis E infection in the context of recent initiation of rituximab therapy...
2024: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38576668/interpreting-a-delayed-workup-of-idiopathic-inflammatory-myopathy
#3
Kristina Terrani, Ramzi Ibrahim, Sean P Ferris, Eric Brucks
Idiopathic inflammatory myopathies are a widely heterogeneous group of muscle diseases and encompass multiple clinicopathologic entities. Our case presentation describes a 70-year-old male who presented with progressively worsening dyspnea, along with worsening proximal muscle weakness in the bilateral lower extremities. Extensive clinical evaluation revealed a creatine kinase level of 105 IU/L, severe and chronic widespread myopathy seen on electromyography (EMG), and asymmetric but widespread muscle atrophy with fibro-fatty replacement seen on ultrasonography...
March 2024: Curēus
https://read.qxmd.com/read/38567566/characteristics-of-chest-high-resolution-computed-tomography-in-patients-with-anti-aminoacyl-trna-synthetase-antibody-positive-interstitial-lung-disease
#4
JOURNAL ARTICLE
Masato Mima, Seidai Sato, Takayoshi Shinya, Nobuhito Naito, Takatoshi Shoji, Saki Harada, Ryoko Suzue, Kojin Murakami, Kazuya Koyama, Yasuhiko Nishioka
BACKGROUND AND AIM: Anti-aminoacyl-tRNA synthetase (ARS) antibodies form a condition called Antisynthetase syndrome (ASSD). While interstitial lung disease (ILD) is a particularly frequent manifestation of ASSD and is closely associated with morbidity and mortality, few studies have been conducted on its characteristics on high-resolution computed tomography (HRCT). In this study, we clarified the HRCT findings in patients with anti-ARS antibody-positive ILD (ARS-ILD).  Methods: The HRCT findings at the time of the ILD diagnosis in 24 ARS-ILD patients were retrospectively evaluated by 2 pulmonologists and one radiologist...
March 26, 2024: Sarcoidosis, Vasculitis, and Diffuse Lung Diseases: Official Journal of WASOG
https://read.qxmd.com/read/38567480/unprecedented-complexity-of-six-coexisting-autoimmune-diseases-a-case-report
#5
REVIEW
Jihed Anoun, Nourhen Guedri, Imen Ben Hassine, Wafa Baya, Anis Mzabi, Fatma Ben Fredj
INTRODUCTION: Autoimmune disorders often exhibit interconnectedness, although encountering multiple autoimmune conditions in a single patient is uncommon. Multiple autoimmune syndrome is characterized by the presence of at least three distinct autoimmune diseases in an individual. This report outlines the case of a middle-aged woman diagnosed with autoimmune thyroiditis, Sjögren's syndrome, scleroderma, autoimmune hepatitis, primary biliary cirrhosis, and antisynthetase syndrome...
February 5, 2024: La Tunisie Médicale
https://read.qxmd.com/read/38544289/title-sarcopenia-assessed-by-dxa-and-hand-grip-dynamometer-a-potential-marker-of-damage-disability-and-myokines-imbalance-in-inflammatory-myopathies
#6
JOURNAL ARTICLE
Margherita Giannini, Anne-Laure Charles, Charles Evrard, Julien Blaess, Maude Bouchard-Marmen, Léa Debrut, Simone Perniola, Gilles Laverny, Rose-Marie Javier, Anne Charloux, Bernard Geny, Alain Meyer
OBJECTIVES: To assess the ability of dual-energy X-ray absorptiometry (DXA) and hand-grip dynamometer to measure damage in inflammatory myopathies (IM). METHODS: . Forty adult IM patients with a disease duration ≥12 months, low or no disease activity for ≥6 months, were prospectively enrolled. Thirty healthy age and sex-matched volunteers were enrolled as controls. Whole-body DXA and hand-grip dynamometer were used to measure muscle mass, grip strength and diagnose sarcopenia (EWGSOP2 criteria)...
March 27, 2024: Rheumatology
https://read.qxmd.com/read/38494286/paraneoplastic-myopathies
#7
REVIEW
Andrew L Mammen
This chapter reviews the association between cancer and the idiopathic inflammatory myopathies (IIM), which includes dermatomyositis (DM), antisynthetase syndrome (ASyS), immune-mediated necrotizing myopathy (IMNM), and inclusion body myositis (IBM). Accumulating evidence shows that the risk of a coexisting malignancy is high in patients with DM, especially among those with anti-Tif1γ autoantibodies. Patients with IMNM and no defined autoantibodies also have an increased risk of malignancy. Recent evidence demonstrates that many IBM patients have increased numbers of circulating CD57+ CD8+ T cells, consistent with a diagnosis of large granular lymphocytic leukemia...
2024: Handbook of Clinical Neurology
https://read.qxmd.com/read/38488306/evaluating-disease-status-in-idiopathic-inflammatory-myopathies-with-quantitative-muscle-ultrasound
#8
JOURNAL ARTICLE
Jie Ying Tan, Cheng Yin Tan, Mohd Azly Yahya, Nortina Shahrizaila, Khean Jin Goh
INTRODUCTION/AIMS: Muscle strength, functional status, and muscle enzymes are conventionally used to evaluate disease status in idiopathic inflammatory myopathies (IIM). This study aims to investigate the role of quantitative muscle ultrasound in evaluating disease status in IIM patients. METHODS: Patients with IIM, excluding inclusion body myositis, were recruited along with age- and sex-matched healthy controls (HC). All participants underwent muscle ultrasound and clinical assessments...
March 15, 2024: Muscle & Nerve
https://read.qxmd.com/read/38488096/subclinical-myocardial-involvement-in-a-cohort-of-patients-with-antisynthetase-syndrome
#9
JOURNAL ARTICLE
Albert Gil-Vila, Gemma Burcet-Rodriguez, Ernesto Trallero-Araguás, Hug Cuellar-Calabria, Albert Selva-O'Callaghan
OBJECTIVES: There is an increasing interest in knowing whether patients with antisynthetase syndrome (ASSD) may have silent myocardial interstitial involvement. Mapping techniques in cardiac magnetic resonance (CMR) can detect subclinical myocardial involvement. The purpose of this study was to identify alterations in multiparametric CMR in ASSD patients without overt cardiac involvement. METHODS: Patients diagnosed with ASSD underwent a CMR along with the standard clinical workup, investigation of specific and associated myositis antibodies, and high-resolution chest CT...
February 2024: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/38464923/clinical-evolution-of-antisynthetase-syndrome-associated-interstitial-lung-disease-after-covid-19-in-a-man-with-klinefelter-syndrome-a-case-report
#10
Xiang-Xiang Wu, Jian Cui, Shi-Yao Wang, Tian-Tian Zhao, Ya-Fei Yuan, Long Yang, Wei Zuo, Wen-Jian Liao
BACKGROUND: This study presents a case of rapidly developing respiratory failure due to antisynthetase syndrome (AS) following coronavirus disease 2019 (COVID-19) in a 33-year-old man diagnosed with Klinefelter syndrome (KS). CASE SUMMARY: A 33-year-old man with a diagnosis of KS was admitted to the Department of Pulmonary and Critical Care Medicine of a tertiary hospital in China for fever and shortness of breath 2 wk after the onset of COVID-19. Computed tomography of both lungs revealed diffuse multiple patchy heightened shadows in both lungs, accompanied by signs of partial bronchial inflation...
February 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38446195/the-relationship-between-anti-ssa-52-and-interstitial-lung-disease
#11
JOURNAL ARTICLE
Hollie Saunders, Hassan Baig, Yan Li, Launia White, David Hodge, Elizabeth Lesser, Justin T Stowell, Carlos A Rojas, Isabel Mira-Avendano
OBJECTIVE: The aims of this study were to assess whether a relationship between anti-SSA-52 and interstitial lung disease (ILD) can be further defined, and to enhance screening, detection, and potentially guide treatment. METHODS: A historical cohort study of 201 patients was conducted at a single tertiary care center between January 1, 2016 and December 31, 2020. All included patients were anti-SSA-52 antibody positive. Chart review was performed for laboratory values, symptoms, pulmonary function tests, treatment, and imaging...
March 5, 2024: Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases
https://read.qxmd.com/read/38438820/quantitative-whole-body-muscle-mri-in-idiopathic-inflammatory-myopathies-including-polymyositis-with-mitochondrial-pathology-indications-for-a-disease-spectrum
#12
JOURNAL ARTICLE
Lea-Katharina Zierer, Steffen Naegel, Ilka Schneider, Thomas Kendzierski, Kathleen Kleeberg, Anna Katharina Koelsch, Leila Scholle, Christoph Schaefer, Arne Naegel, Stephan Zierz, Markus Otto, Gisela Stoltenburg-Didinger, Torsten Kraya, Dietrich Stoevesandt, Alexander Mensch
OBJECTIVE: Inflammatory myopathies (IIM) include dermatomyositis (DM), sporadic inclusion body myositis (sIBM), immune-mediated necrotizing myopathy (IMNM), and overlap myositis (OLM)/antisynthetase syndrome (ASyS). There is also a rare variant termed polymyositis with mitochondrial pathology (PM-Mito), which is considered a sIBM precursor. There is no information regarding muscle MRI for this rare entity. The aim of this study was to compare MRI findings in IIM, including PM-Mito. METHODS: This retrospective analysis included 41 patients (7 PM-Mito, 11 sIBM, 11 PM/ASyS/OLM, 12 IMNM) and 20 healthy controls...
March 5, 2024: Journal of Neurology
https://read.qxmd.com/read/38436279/performance-of-the-2017-eular-acr-classification-criteria-for-adult-and-juvenile-idiopathic-inflammatory-myopathies-and-their-major-subgroups-a-scoping-review
#13
REVIEW
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, Matteo Bottai, Marianne de Visser, Mazen M Dimachkie, David Fiorentino, Ingrid Gerhardson, Masataka Kuwana, Frederick W Miller, Merrilee Needham, Lisa G Rider, Yasser Salem, Silke Schlüter, Samuel K Shinjo, Guochun Wang, Victoria P Werth, Rohit Aggarwal, Ingrid E Lundberg
The 2017 EULAR/ACR classification criteria for adult/juvenile idiopathic inflammatory myopathies (IIM) were established using a data-driven approach by an international group of myositis experts to allow classification of IIM and its major subtypes. Since their publication, the performance of the criteria has been tested in multiple cohorts worldwide and significant limitations have been identified. Moreover, the understanding and classification of IIM have evolved since 2017. This scoping review was undertaken as part of a large international project to revise the EULAR/ACR criteria and aims to i) summarise the evidence from the current literature on the performance characteristics of the 2017 EULAR/ACR classification criteria in various cohorts and IIM subtypes, and ii) delineate the factors that need to be considered in the revision of the classification criteria...
February 28, 2024: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/38395605/novel-endotypes-of-antisynthetase-syndrome-identified-independent-of-anti-aminoacyl-transfer-rna-synthetase-antibody-specificity-that-improve-prognostic-stratification
#14
JOURNAL ARTICLE
Shiyu Wu, Xinyue Xiao, Yingfang Zhang, Xinxin Zhang, Guochun Wang, Qinglin Peng
OBJECTIVES: To systemically analyse the heterogeneity in the clinical manifestations and prognoses of patients with antisynthetase syndrome (ASS) and evaluate the transcriptional signatures related to different clinical phenotypes. METHODS: A total of 701 patients with ASS were retrospectively enrolled. The clinical presentation and prognosis were assessed in association with four anti-aminoacyl transfer RNA synthetase (ARS) antibodies: anti-Jo1, anti-PL7, anti-PL12 and anti-EJ...
February 29, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38372203/myxovirus-resistance-protein-a-mxa-expression-in-myositides-sarcoplasmic-expression-is-common-in-both-dermatomyositis-and-lupus-myositis
#15
JOURNAL ARTICLE
Changhong Xing, Jaya Trivedi, Nicole Bitencourt, Dennis K Burns, Joan S Reisch, Chunyu Cai
INTRODUCTION/AIMS: Myxovirus resistance protein A (MxA) is a type I interferon (IFN1) pathway activation marker and MxA sarcoplasmic expression is currently recognized as a highly specific marker for dermatomyositis (DM). However, we have frequently observed endothelial tubuloreticular inclusions (TRI), another surrogate IFN1 activation marker, in a variety of overlap myositides. The aim of this study was to examine MxA expression in those myositides. METHODS: We retrospectively performed MxA immunostaining on a wide range of myositides...
February 19, 2024: Muscle & Nerve
https://read.qxmd.com/read/38346432/antisynthetase-syndrome-causing-necrotizing-myositis-involving-extraocular-muscles
#16
JOURNAL ARTICLE
Lisa Y Lin, Amee D Azad, Carolina A Chiou, Liana Kozanno, Anat Stemmer-Rachamimov, John Stone, Nahyoung Grace Lee
The authors describe the clinical, histologic, and serologic findings of a patient with necrotizing myositis of the extraocular muscles in the setting of antisynthetase syndrome, as well as subsequent management. This is the first case in the literature of a systemic necrotizing myositis to have associated ophthalmic findings.
February 9, 2024: Ophthalmic Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38282927/long-term-outcomes-in-idiopathic-inflammatory-myositis-an-observational-epidemiologic-study-over-15-years
#17
JOURNAL ARTICLE
Ramya Janardana, Sangeetha Kn, Vasudha Bhat, Divya Balakrishnan, John Michael Raj, Benzeeta Pinto, Chanakya K, Raghunandan Nadig, Anita Mahadevan, Vineeta Shobha
BACKGROUND: We report a longitudinal observational cohort of idiopathic inflammatory myositis (IIM) focusing on the long-term clinical outcome and associated parameters. METHODS: IIM patients were classified as per Bohan and Peter criteria. In those with ≥ 24 months of follow-up; the treatment response, functional outcomes, and damage at last follow-up were recorded. Complete clinical response and clinical remission as defined by Oddis et al., was used to define outcomes at last follow-up...
December 2023: Mediterranean journal of rheumatology
https://read.qxmd.com/read/38242552/upadacitinib-therapy-in-refractory-inflammatory-myositis-a-case-series-of-10-patients
#18
JOURNAL ARTICLE
Madelaine Beckett, Jan Dutz, Kun Huang
OBJECTIVES: To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis. METHODS: Patients with refractory inflammatory myositis treated with upadacitinib from a single urban centre in Vancouver, British Columbia, Canada, were included from September 2020 to June 2023. The medical records of these patients were retrospectively reviewed. RESULTS: 10 total patients were identified for review, including 5 classic dermatomyositis (DM), 3 amyopathic DM (ADM) and 2 antisynthetase syndrome...
January 18, 2024: RMD Open
https://read.qxmd.com/read/38128034/comment-on-rescue-therapy-of-antisynthetase-syndrome-with-cd19-targeted-car-t-cells-after-failure-of-several-b-cell-depleting-antibodies
#19
JOURNAL ARTICLE
Nikolas Ruffer, Martin Krusche, Werner Stenzel, Udo Schneider
No abstract text is available yet for this article.
December 21, 2023: Rheumatology
https://read.qxmd.com/read/38127905/comment-on-rescue-therapy-of-antisynthetase-syndrome-with-cd19-targeted-car-t-cells-after-failure-of-several-b-cell-depleting-antibodies-reply
#20
JOURNAL ARTICLE
Jule Taubmann, Johannes Knitza, Fabian Müller, Simon Völkl, Michael Aigner, Sascha Kretschmann, Armin Atzinger, Torsten Kuwert, Andreas Mackensen, Georg Schett
No abstract text is available yet for this article.
December 21, 2023: Rheumatology
keyword
keyword
109480
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.